Case Report: Identification of novel CDH2 mutation (p. P183A het)-induced arrhythmogenic cardiomyopathy in China

Kun Li1, Yifei Wang1, Jing Yang1

  • 1Department of Cardiology, School of Clinical Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China.

PubMed

Insights

This study reports a novel CDH2 gene mutation in a 10-year-old Chinese patient with arrhythmogenic cardiomyopathy. This finding reveals a new mechanism for arrhythmogenic cardiomyopathy involving cell-cell adhesion disruption.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Pediatric Cardiology

Background:

  • Arrhythmogenic cardiomyopathy (ACM) is an inherited heart condition characterized by fibrofatty replacement of the heart muscle.
  • Genetic variations are a primary cause of ACM, increasing the risk of arrhythmias and sudden cardiac death.

Observation:

  • A 10-year-old patient presented with palpitations, premature ventricular contractions, and an epsilon wave on ECG.
  • Echocardiography revealed right ventricular enlargement, leading to a clear ACM diagnosis.
  • Genetic analysis identified a novel heterozygous missense mutation in the CDH2 gene (c.547C>G, p.P183A).

Findings:

  • This is the first reported case of CDH2 mutation-related ACM in the Chinese population.
  • The identified mutation (p.P183A) potentially disrupts adherens junctions in intercalated discs.
  • This represents a novel mechanism for ACM, distinct from previously described desmosome-related mutations.

Implications:

  • The findings expand the understanding of genetic underpinnings of arrhythmogenic cardiomyopathy.
  • CDH2 mutations affecting cell-cell adhesion offer a new therapeutic target for ACM.
  • This case highlights the importance of genetic testing in pediatric patients with unexplained arrhythmias.
Abstract